Physician profile
Kyle Hirsch
NPI 1447022827
$2,393.46
in general payments reported to CMS, 2019-2025
15 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,365 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,248 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,247.96 |
| Education | $145.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $577.15 | 2024-2025 | Adbry, Anzupgo |
| Ucb, INC. | $324.05 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $308.17 | 2024-2025 | Dupixent |
| Dermavant Sciences, INC. | $255.39 | 2024 | Vtama |
| Genzyme Corporation | $200.34 | 2024-2025 | |
| Amgen INC. | $140.75 | 2024-2025 | Otezla, Otezla |
| Abbvie INC. | $133.84 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $94.30 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $72.98 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $72.00 | 2024 | |
| Janssen Biotech, INC. | $71.70 | 2024-2025 | Tremfya |
| Galderma Laboratories, L.P. | $59.94 | 2025 | Nemluvio |
| Organon LLC | $35.29 | 2025 | Vtama |
| Incyte Corporation | $26.31 | 2025 | Opzelura |
| Lilly USA, LLC | $21.25 | 2024 | Taltz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.